Unfortunately, a jason napodano said do not expect ACAD to partner until after ACAD files for the sNDA. Originally he believed ACAD would partner soon in 2013. The goods news is he said expect ACAD to initiate a phase 2 in Alzheimer's
I was hoping it would drop a buck today :-) (kidding).
But seriously, it would not matter to me if it dropped $2 or went up $2 today. This will play out over time and there are a few catalysts that could cause it to go up. I list some below (nothing new here...stuff others have stated), but I really don't see anything that will drive it down for very long and with a reason. This is why I don't understand anyone shorting it for more than a day or two at a time....any one of these can wake you up one morning with a migraine if you are caught being short:
- announce info about PDP and/or ADP trial (schizo with risperidone (sp?) drug)
- buyout (very bad migraine)
- insider buying (not sure anyone has factored this in, but it will cause a jolt)
- other small bios being acquired....all the boats go up with a rising tide